Old drug fluvoxamine, new hope for COVID-19
Yaeko Hashimoto, Takuji Suzuki, Kenji Hashimoto
Topics & Concepts
FluvoxamineCoronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)DrugMedicineMEDLINEPsychologyPsychiatryPsychoanalysisPharmacologyVirologyInternal medicinePolitical scienceFluoxetineOutbreakDiseaseLawReceptorSerotoninInfectious disease (medical specialty)Pharmacological Receptor Mechanisms and EffectsTryptophan and brain disordersEpilepsy research and treatment